Dominant Dystrophic Epidermolysis BullosaSymptoms, Doctors, Treatments, Advances & More
Dominant Dystrophic Epidermolysis Bullosa Overview
Learn About Dominant Dystrophic Epidermolysis Bullosa
- Dominant dystrophic epidermolysis bullosa
- Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types
- DDEB, Pasini and Cockayne-Touraine types
- DDEB, generalized
- DDEB-gen
- Dominant dystrophic epidermolysis bullosa, generalized
- Dystrophic epidermolysis bullosa, autosomal dominant
- Epidermolysis bullosa dystrophica, Cockayne-Touraine type (formerly)
- Epidermolysis bullosa dystrophica, Pasini type (formerly)
- Epidermolysis bullosa dystrophica, autosomal dominant
- Generalized dominant dystrophic epidermolysis bullosa
Dermatologists Of Southwest Ohio, Inc.
Anne Lucky is a Dermatologist practicing medicine in Blue Ash, Ohio. Dr. Lucky is rated as an Elite provider by MediFind in the treatment of Dominant Dystrophic Epidermolysis Bullosa. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, and Dominant Dystrophic Epidermolysis Bullosa. Dr. Lucky is board certified in American Board Of Pediatrics and American Board Of Dermatology . Dr. Lucky is currently accepting new patients.
Catherine Laprise practices practicing medicine in Saguenay, Canada. Ms. Laprise is rated as an Elite expert by MediFind in the treatment of Dominant Dystrophic Epidermolysis Bullosa. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Asthma, and Epidermolysis Bullosa.
Cristina Has practices practicing medicine in Freiburg, Germany. Ms. Has is rated as an Elite expert by MediFind in the treatment of Dominant Dystrophic Epidermolysis Bullosa. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Dominant Dystrophic Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, and Junctional Epidermolysis Bullosa.
Summary: This Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (2 years of age and older) diagnosed with localized, intermediate, or severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) will be enrolled in the study and will be randomized to receive either TolaSure Gel or a topical Placebo for daily appli...
Summary: The goal of this clinical trial is to learn about deucravacitinib treatment in adults with inflammatory epidermal genodermatoses . The main question it aims to answer are: describe efficacity and safety of this treatment. Participants will take treatments and have to use bullets during the study period.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center